
Agilent Technologies A
€ 117.47
-1.35%
Quartalsbericht 2026-Q2
hinzugefügt 01.06.2026
Agilent Technologies EV/EBITDA 2011-2026 | A
EV/EBITDA Jährlich Agilent Technologies
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 20.2 | 24.5 | 23.1 | 21.2 | 27.4 | 32 | 22.4 | 20 | 20.5 | 16.2 | 17.5 | 11.5 | 9.89 | 6.72 | 6.02 | 15.1 | 34.9 | 12.7 | -2.36 | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 34.9 | -2.36 | 17.9 |
EV/EBITDA anderer Aktien in der Diagnostik & Forschung
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
2.04 | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
-134 | - | - | $ 1.31 B | ||
|
Celcuity
CELC
|
-32.4 | $ 90.27 | -2.38 % | $ 4.22 B | ||
|
Akumin
AKU
|
23.4 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
0.0391 | $ 5.31 | -7.9 % | $ 7.06 M | ||
|
Fulgent Genetics
FLGT
|
-8.71 | $ 19.07 | -2.21 % | $ 587 M | ||
|
Castle Biosciences
CSTL
|
-227 | $ 21.32 | -1.3 % | $ 618 M | ||
|
Aspira Women's Health
AWH
|
-1.36 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-2.05 | - | -61.36 % | $ 2.46 M | ||
|
Guardant Health
GH
|
-38.2 | $ 128.48 | -3.44 % | $ 16.1 B | ||
|
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | ||
|
Interpace Biosciences
IDXG
|
3.62 | $ 1.79 | 2.29 % | $ 7.92 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | ||
|
Illumina
ILMN
|
22.1 | $ 162.96 | -3.03 % | $ 25.3 B | ||
|
CareDx, Inc
CDNA
|
-100 | $ 22.34 | -3.37 % | $ 1.19 B | ||
|
Chembio Diagnostics
CEMI
|
-1.86 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
0.000843 | - | - | $ 9.42 M | ||
|
ICON Public Limited Company
ICLR
|
20 | $ 149.93 | -1.88 % | $ 11.8 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.156 | - | -20.0 % | $ 1.06 M | ||
|
Lantheus Holdings
LNTH
|
15.5 | $ 102.87 | 0.05 % | $ 6.94 B | ||
|
Global Cord Blood Corporation
CO
|
-4.15 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | ||
|
NeoGenomics
NEO
|
-33.5 | $ 11.04 | -2.39 % | $ 1.41 B | ||
|
Charles River Laboratories International
CRL
|
26.6 | $ 184.42 | -0.75 % | $ 9.14 B | ||
|
Natera
NTRA
|
-112 | $ 218.67 | -1.55 % | $ 29.9 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | ||
|
Medpace Holdings
MEDP
|
30.7 | $ 456.62 | -0.45 % | $ 13.2 B | ||
|
Mettler-Toledo International
MTD
|
627 | $ 1 151.41 | -2.46 % | $ 23.7 B | ||
|
Exact Sciences Corporation
EXAS
|
-20.8 | - | - | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
-1.79 | $ 4.7 | 0.11 % | $ 435 M | ||
|
National Research Corporation
NRC
|
14.3 | $ 19.4 | -1.77 % | $ 434 M | ||
|
Personalis
PSNL
|
-4.87 | $ 11.42 | -5.62 % | $ 1.02 B | ||
|
Koninklijke Philips N.V.
PHG
|
17.1 | $ 26.22 | 0.87 % | $ 24.9 B | ||
|
Senseonics Holdings
SENS
|
-5.62 | $ 6.8 | -3.0 % | $ 284 M | ||
|
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
186 | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
-6.24 | $ 2.15 | 0.09 % | $ 4.94 M | ||
|
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 264.51 | 1.3 % | $ 22 B | ||
|
Twist Bioscience Corporation
TWST
|
-23.6 | $ 71.41 | -3.41 % | $ 4.27 B | ||
|
Thermo Fisher Scientific
TMO
|
19.3 | $ 474.35 | -1.6 % | $ 179 B | ||
|
Trinity Biotech plc
TRIB
|
-15.5 | $ 0.71 | 3.07 % | $ 255 M | ||
|
Motus GI Holdings
MOTS
|
-0.0496 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
40.3 | $ 8.96 | -1.75 % | $ 1.94 B | ||
|
Quest Diagnostics Incorporated
DGX
|
5.51 | $ 199.73 | 1.82 % | $ 22.2 B | ||
|
Invitae Corporation
NVTA
|
44.6 | - | - | $ 21.2 M | ||
|
Waters Corporation
WAT
|
60.2 | $ 367.41 | -2.4 % | $ 21.9 B |